Breaking: What’s Propelling Heska Corp to Increase So Much?

Breaking: What's Propelling Heska Corp to Increase So Much?

The stock of Heska Corp (NASDAQ:HSKA) is a huge mover today! About 89,631 shares traded hands. Heska Corp (NASDAQ:HSKA) has risen 74.46% since March 7, 2016 and is uptrending. It has outperformed by 66.87% the S&P500.
The move comes after 6 months positive chart setup for the $388.04 million company. It was reported on Oct, 10 by Barchart.com. We have $159.19 PT which if reached, will make NASDAQ:HSKA worth $706.23 million more.

Analysts await Heska Corp (NASDAQ:HSKA) to report earnings on November, 9. They expect $0.26 EPS, up 30.00% or $0.06 from last year’s $0.2 per share. HSKA’s profit will be $1.79M for 54.28 P/E if the $0.26 EPS becomes a reality. After $0.35 actual EPS reported by Heska Corp for the previous quarter, Wall Street now forecasts -25.71% negative EPS growth.

Heska Corp (NASDAQ:HSKA) Ratings Coverage

Out of 2 analysts covering Heska Corp (NASDAQ:HSKA), 0 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 0 are positive. Heska Corp has been the topic of 3 analyst reports since August 25, 2015 according to StockzIntelligence Inc. TheStreet upgraded Heska Corp (NASDAQ:HSKA) on Tuesday, August 25 to “Hold” rating. The firm has “Neutral” rating given on Friday, April 1 by CL King. The firm has “Hold” rating given on Thursday, August 4 by Gabelli.

According to Zacks Investment Research, “Heska Corporation is focused on the discovery, development and marketing of companion animal health products. In addition to manufacturing certain of companion animal products, the company’s primary manufacturing subsidiary, Diamond Animal Health, Inc., also manufactures animal health vaccine products which are marketed and distributed by third parties. In addition to manufacturing veterinary allergy products for marketing and sale by the company, subsidiaries, Center Laboratories, Inc. and CMG-Heska Allergy Products S.A., also manufacture and sell human allergy products.”

Insitutional Activity: The institutional sentiment increased to 1.54 in 2016 Q2. Its up 0.10, from 1.44 in 2016Q1. The ratio increased, as 6 funds sold all Heska Corp shares owned while 29 reduced positions. 24 funds bought stakes while 30 increased positions. They now own 4.56 million shares or 4.63% more from 4.36 million shares in 2016Q1.
Walleye Trading Ltd Liability Company, a Minnesota-based fund reported 400 shares. The New York-based Tower Research Cap Limited Liability (Trc) has invested 0% in Heska Corp (NASDAQ:HSKA). Fuller Thaler Asset Management Inc has 1,500 shares for 0% of their US portfolio. Citigroup has 0% invested in the company for 1,910 shares. Rhumbline Advisers accumulated 0% or 5,966 shares. The Oregon-based Tygh Mgmt has invested 1.59% in Heska Corp (NASDAQ:HSKA). Oberweis Asset Inc, a Illinois-based fund reported 21,544 shares. Hatteras Funds Lc holds 2.29% of its portfolio in Heska Corp (NASDAQ:HSKA) for 11,010 shares. Manufacturers Life Insur The reported 4,711 shares or 0% of all its holdings. Blackrock has invested 0% of its portfolio in Heska Corp (NASDAQ:HSKA). Cortina Asset Mgmt last reported 0.27% of its portfolio in the stock. California State Teachers Retirement Systems accumulated 0% or 12,790 shares. Art Limited Liability, a New York-based fund reported 8,544 shares. Aqr Cap Mgmt Limited Liability Co last reported 0% of its portfolio in the stock. Bnp Paribas Arbitrage Sa, a New York-based fund reported 241 shares.

Insider Transactions: Since May 3, 2016, the stock had 0 buys, and 17 sales for $6.96 million net activity. 5,000 shares were sold by Wilson Kevin S., worth $192,500. McMahon John sold 137 shares worth $7,028. On Tuesday, August 9 the insider Asakowicz Steve sold $246,864. Shares for $262,642 were sold by NAPOLITANO JASON A. 5,998 shares with value of $218,927 were sold by McGinley Michael J on Tuesday, May 10. 15,000 shares were sold by Riley Sharon L., worth $534,863 on Thursday, May 5.

More recent Heska Corp (NASDAQ:HSKA) news were published by: Marketwatch.com which released: “Heska downgraded to neutral from buy at B. Riley” on December 21, 2009. Also Quotes.Wsj.com published the news titled: “News Heska Corp.HSKA” on February 12, 2011. Prnewswire.com‘s news article titled: “Heska Announces Executive Promotions to Further Growth Initiatives” with publication date: September 29, 2016 was also an interesting one.

HSKA Company Profile

Heska Corporation, incorporated on March 27, 1997, develops, makes, markets, sells and supports veterinary products. The Firm is focused on the canine and feline companion animal health markets. The Firm operates in two divisions, which include Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use services and products, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals. It sells veterinary diagnostic and other specialty veterinary products. The Company’s offerings include blood testing instruments and supplies, digital imaging products, software and services, and single use services and products, such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment